Giant-cell arteritis. Histological, immunohistochemical and electronmicroscopic studies.
Biopsies from the temporal artery of 32 patients suspected of giant-cell arteritis were evaluated retrospectively by light microscopy, histochemical, and immunohistochemical methods, as well as by transmission electron microscopy (TEM). At the clinical follow-up the 32 patients included four clinical groups: temporal arteritis (8 patients), polymyalgia rheumatica (10 patients), rheumatoid arthritis (4 patients), and a group of miscellaneous diseases unrelated to inflammatory rheumatic diseases (10 patients). There were a number of similarities between age-related alterations in the arteries and the changes in giant-cell arteritis. The most important differences were the inflammatory cellular infiltration of the media, the perifocal accumulation of fibronectin, and the occurrence of deposits of fibrin/fibrinogen and fibrin/fibrinogen degradation products. In addition, alpha-2 macroglobulin, lysozyme and factor VIII were also noted in giant-cell arteritis. The alterations in giant-cell arteritis show a number of similarities to the changes following experimental vascular injury of the rabbit aorta. The nature of the findings in human giant-cell arteritis, as well as the similarity to the experimental arteritis, indicate that giant-cell arteritis may reflect a non-specific reaction to injury, independent of the cause of the disease.
D000368:Aged; D000941:Antigens / Q000032:analysis; D005169:Factor VIII / Q000032:analysis / Q000276:immunology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005353:Fibronectins / Q000032:analysis; D013700:Giant Cell Arteritis / Q000378:metabolism / Q000473:pathology*; D006025:Glycosaminoglycans / Q000032:analysis; D006651:Histocytochemistry; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D009113:Muramidase / Q000032:analysis; D011111:Polymyalgia Rheumatica / Q000378:metabolism / Q000473:pathology*; D000511:alpha-Macroglobulins / Q000032:analysis; D014841:von Willebrand Factor
D000941:Antigens; D005338:Fibrin Fibrinogen Degradation Products; D005353:Fibronectins; D006025:Glycosaminoglycans; D000511:alpha-Macroglobulins; D014841:von Willebrand Factor; D005169:Factor VIII; D009113:Muramidase